These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8131270

  • 1. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry.
    Fitzgerald RL, Rexin DA, Herold DA.
    Clin Chem; 1994 Mar; 40(3):373-80. PubMed ID: 8131270
    [Abstract] [Full Text] [Related]

  • 2. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
    Meatherall R.
    J Anal Toxicol; 1994 Mar; 18(7):385-90. PubMed ID: 7861751
    [Abstract] [Full Text] [Related]

  • 3. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB, Floyd D, Dasgupta A.
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [Abstract] [Full Text] [Related]

  • 4. Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine.
    Augsburger M, Rivier L, Mangin P.
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):681-7. PubMed ID: 9919969
    [Abstract] [Full Text] [Related]

  • 5. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse.
    Koch TR, Raglin RL, Kirk S, Bruni JF.
    J Anal Toxicol; 1994 Dec; 18(3):168-72. PubMed ID: 7914948
    [Abstract] [Full Text] [Related]

  • 6. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.
    Huang W, Moody DE.
    J Anal Toxicol; 1995 Oct; 19(6):333-42. PubMed ID: 8926726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS, Pearlman R, Tsilimidos M, Salamone SJ, Cannon RC, Wong SH, Gock SB, Jentzen JJ.
    J Anal Toxicol; 2000 Oct; 24(8):726-32. PubMed ID: 11110029
    [Abstract] [Full Text] [Related]

  • 9. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF, Klette KL, Stout PR, Gehlhausen JM.
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A, Snyder ML, Ptolemy AS, Melanson S.
    Pain Physician; 2014 Oct; 17(4):359-66. PubMed ID: 25054395
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometry.
    Nishikawa T, Ohtani H, Herold DA, Fitzgerald RL.
    Am J Clin Pathol; 1997 Mar; 107(3):345-52. PubMed ID: 9052386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnostic performance of Triage for benzodiazepines: urine analysis of the dose of therapeutic cases.
    Kurisaki E, Hayashida M, Nihira M, Ohno Y, Mashiko H, Okano T, Niwa S, Hiraiwa K.
    J Anal Toxicol; 2005 Sep; 29(6):539-43. PubMed ID: 16168176
    [Abstract] [Full Text] [Related]

  • 17. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA, Schwarzhoff RH, Hubster EC, Liserio MK.
    Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
    [Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD, Meatherall R.
    J Anal Toxicol; 1996 Oct; 20(4):217-23. PubMed ID: 8835658
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.